Tissue engineering in burn scar reconstruction by unknown
REVIEW Open Access
Tissue engineering in burn scar
reconstruction
PPM van Zuijlen1,2,3,4*, KLM Gardien1,3,4, MEH Jaspers1,2,3,4, EJ Bos4, DC Baas1, AJM van Trier1,2 and E Middelkoop1,3,4
Abstract
Nowadays, most patients with severe burns will survive their injury. This evolution is accompanied by the challenge
to cover a large percentage of total body surface area burned. Consequently, more and more patients have to
deal with the sequelae of burn scars and require (multiple) reconstructions. This review provides a gross overview of
developments in the field of tissue engineering for permanent burn wound coverage and reconstructive burn surgery,
focusing on usage and clinical effectiveness. Not only skin substitutes will be discussed but also the replacement of
subcutaneous fat tissue and cartilage.
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Introduction
Reconstructive surgery has been performed since ancient
times, especially circumstances such as disasters and wars
frequently challenge humanity to innovate. Pioneers like
Sir Harold Gillies and Sir Archibald McIndoe have devel-
oped many techniques for the reconstruction of all sorts
of traumatic wounds during the First and Second World
Wars. During the last World War, many young pilots
crashed with their airplane when it was hit by enemy fire.
Some of them survived the crash and were able to return
to England, but many of them sustained severe burn injur-
ies to the hands and faces. McIndoe treated many of these
war survivors in his hospital in East Grinstead. He did re-
markable work and invented many interesting new flaps
and techniques for burn scar reconstruction. However, at
that time, the survival of patients was poor, especially of
those with extensive burn wounds.
Since then, significant progression has been made con-
cerning the resuscitation and emergency management of
severely burned patients. Most patients with extensive
burns will survive their injuries nowadays. This necessitated
the development of techniques to close wounds of more
than half the body surface area. The autologous split thick-
ness skin graft, which is an epidermal graft with only a thin
dermal layer, became the mainstay of burn surgery because
of donor site availability and of the potential for reuse of the
same site after a couple of weeks. Despite the importance of
this development, this only solved part of the problem.
Expansion techniques such as mesh grafting and Meek
Wall micrografting were developed to improve the
efficacy of autologous split skin grafting [1, 2]. At that
time, closing of the wound, which practically meant re-
storing the epidermis, was the main focus. This explains
why Rheinwald and Green explored the possibility of
culturing keratinocytes to create the first epidermal sub-
stitutes simultaneously in the early 70s [3, 4]. All these
techniques contributed indisputably to closure of extensive
burn wounds mainly by restoring the epidermal layer.
Unfortunately, the grafted areas were known to result
in a scar with a poor esthetic result with functional
problems such as contracture and stiffness. Also, many
location specific complaints, such as ectropion of the
eyelid, nasal obstruction, oral incontinence, swan neck/
boutonniere deformity of the finger, and claw hand may
result in scar formation. Less functional problematic but
also disfiguring are erythema, aberrant pigmentation,
and textural deformities. Pain and mostly itching are
“complaints in disguise” that can be extremely disturbing
for the patient affecting their quality of life [5].
So the closed wound has become a scar that mainly
lacks “dermal qualities” such as flexibility and strength.
However, it is misleading to conclude that thicker split
thickness skin grafts should be used to provide the best
outcome in terms of scar formation because donor sites
* Correspondence: pvanzuijlen@rkz.nl
1Burn Center, Red Cross Hospital, Beverwijk, The Netherlands
2Department of Plastic, Reconstructive and Hand Surgery, Red Cross Hospital,
Beverwijk, The Netherlands
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
van Zuijlen et al. Burns & Trauma  (2015) 3:18 
DOI 10.1186/s41038-015-0017-5
heal more problematic after harvesting thicker split
thickness grafts. Certainly in extensively burned patients,
where donor sites may have to be used several times, it
is therefore advised to use thin split skin grafts because
these donor sites will heal quickly and spontaneously.
In the 1970s, it was already concluded that there is
not sufficient autologous dermis available for trans-
plantation of large defects. This challenged the sur-
geons and researchers to engineer dermal like tissue in
the lab. Tissue engineering of a dermis seemed the lo-
gical choice. Since then, many studies on dermal sub-
stitution have become available. Products have been
developed and some, like Integra and MatriDerm, have
become commercially available and proved to be a
valuable addition to the armamentarium for burn
wound treatment. Table 1 provides an overview of a
selection of commercially available skin substitutes.
This review provides a gross overview of tissue-
engineered products developed for permanent burn
wound coverage and scar reconstruction. It will mainly
concern epidermal and dermal substitutes, but it will also
clearly extend its view beyond the skin because subcutane-
ous fat and cartilage are becoming more interesting from
a tissue engineering perspective.
Nowadays, the role of the subcutis as a gliding layer
for the scarred skin has been well appreciated. Burn scar
reconstruction clearly also focuses on restoring the sub-
cutaneous layer. At the same time, tissue engineering of
cartilage became of interest for reconstruction of ears
and nose after severe facial burns.
Review
Tissue engineering
The term “tissue engineering” is associated with the
repair of body tissues making use of cells, artificially
created lattices and/or specific biochemical substances.
Stem cells or progenitor cells can also be used to pro-
duce tissues. Twenty years ago, these three strategies for
the creation of new tissue were already described by
Langer and Vacant (i.e., isolated cells or cell substitutes,
tissue-inducing substances, and cells placed on or within
matrices) [6]. Tissue-engineered constructs like cartilage,
blood vessels, bladder, skin, and muscle are now being
created in the lab and some have clinical applications.
Some tissues, like the epidermis, consist predomin-
antly out of cells and can be engineered by cell culturing
techniques. But other tissues, like cartilage, are mainly
made of an extracellular matrix that provides 3D form
and mechanical properties to the tissue. The matrix also
serves as a template for the cells (chondrocytes). Ear car-
tilage is a good example where structure and function
are of uttermost importance. Engineering of ear cartilage
without providing a sustainable 3D structure with appro-
priate elasticity is not clinically relevant. Thus, a template
has to be fabricated in optimal 3D ear form which mean-
while supports the cells and their function in creating and
maintaining their normal extracellular matrix. This is an
interesting topic at the moment where tissue engineering
and 3D printing are merging.
An overview is given below on developments in the
field of tissue engineering concerning reconstructive
Table 1 A selection of commercially available skin substitutes
Product Manufacturer Basic composition
Bilayered (dermo-epidermal) substitutes
Apligraf ® Organogenesis Inc., MA, USA Bovine collagen I gel with allogeneic human keratinocytes and fibroblasts
OrCel ™ Forticell Bioscience Inc., NY, USA Bovine collagen sponge with allogeneic fibroblasts and keratinocytes
Epidermalsubstitutes
Epicel ® Genzyme Corporation, Cambridge MA, USA Cultured substitute: autologous keratinocytes with murine fibroblasts
Laserskin ® Fidia Advanced Biopolymers, Abano Terme, Italy Cultured substitute: benzyl esterified hyaluronic acid derivative with
autologous keratinocytes
Dermalsubstitutes
Matriderm ® MedSkin Solutions Dr. Suwelack AG, Billerbeck, Germany Acellular bovine dermis
Alloderm ® LifeCell Corporation, Bridgewater, NJ, USA Acellular human dermis
Integra ® Integra Life Sciences Corp., NJ, USA Bovine collagen and glycosaminoglycan with silicone top layer
Oasis ® Smith & Nephew Inc. Fort Worth, TX, USA Porcine small intestine submucosa
Glyaderm ® Euro Skin Bank (ESB), Beverwijk, The Netherlands. Acellular human dermis
Permacol ™ Covedien, Mansfiels, MA, USA Acellular porcine dermis
Graftjacket ® Wright Medical technology Inc., Memphis, TN, USA Acellular human dermis
Dermagraft ® Organogenesis Inc., MA, USA Allogeneic human fibroblasts and polyglactin mesh scaffold
EZ Derm ® Mölnlycke Health Care AB, Gothenburg, Sweden Porcine collagen dermis
Overview of commercially available epidermal, dermal, and complete skin substitutes for wound repair
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burn surgery. Therefore, not only skin substitutes will be
discussed but also the replacement of subcutaneous fat
tissue and cartilage. This review focuses on permanent
substitutes and not on products engineered for temporary
replacement, such as tissue-engineered wound dressings
based on allogeneic cells.
Epidermal substitutes
Rheinwald and Green were the first to report a success-
ful method to culture keratinocyte colonies from single-
cell suspensions of human epidermal cells in 1975 [4].
This technique was potentially life-saving at that time as it
could facilitate wound closure for patients that survived
extensive burn wounds especially when donor site avail-
ability was limited. Since then, cultured epithelial autograft
(CEA) became available to be used as confluent sheets to
provide permanent burn wound coverage. Six years after
Rheinwald and Green’s publication, the first clinical appli-
cation was reported [7]. The technique has been used
worldwide for many cases.
Clinical studies demonstrated variable successes; a
major concern was the poor survival of the keratino-
cyte sheets [8]. A meta-analysis on graft survival
showed a poor survival of about 60 %. The main causes
of graft failure were wound infection and hemorrhage
[9, 10].
In 2007, Atiyeh et al. reviewed the successes and
problems of CEA for burn treatment in more than three
decades [11].
Besides its potential as a method to provide permanent
wound closure for extremely burned patients, the weak-
nesses of this treatment also became obvious. Its wide-
spread use has been hampered by delays caused by the
time necessary to culture enough keratinocytes to cover
extensive burn wounds. Obviously, large expansion rates
are required for extremely burned patients and culturing
cells into sheets then may take 3 or 4 weeks. This can be
problematic from a clinical perspective. Another fre-
quent criticism of CEA is their extreme fragility and sus-
ceptibility for bacterial contamination. Atiyeh concluded
that the initial optimism for cultured keratinocyte grafts
has gradually declined. In the long term, easy blister for-
mation of the treated area was noted because of a lack
of formation of anchoring filaments at the level of the
basement membrane.
Others also stressed the uncertainty of the take rate,
the high cost, and the problematic scarring in deep burn
injuries because of the lack of dermis [12].
There are several commercially available epidermal
substitutes available; most of them are applied for acute
burn wound treatment. Unfortunately, there is still a
lack of randomized controlled trials, and the use of good
outcome parameters is limited [13]. To circumvent such
problems such as the reduced take rate and the critical
delay in time to produce multi-layered keratinocytes
sheets, new delivery systems have been developed to
transfer keratinocytes.
The development of biocompatible carriers for single-
layered keratinocytes allowed grafting at earlier culturing
stages [14, 15]. The concept of using pre-confluent kera-
tinocytes, where colonies of keratinocytes are grafted
onto the wound bed before they form a sheet, has also
been used [11].
Another option is to prepare an epidermal cell
spray directly during surgery. This can be done on
site by special kits that are developed for this pur-
pose, such as ReCell (Avita Medical Europe Ltd, Mel-
bourn, UK,). Usually a thin split thickness skin graft
is harvested because this allows better separation of
the epidermal layer from the dermal layer, facilitating
the isolation of epidermal cells. This can be useful for
indications of small burns where no culturing time is
required. However, Gravante et al. compared the
ReCell procedure with the standard transplantation of
autologous skin grafting and concluded that the
ReCell procedure took more time and thus costs (op-
erating room) without real benefit regarding func-
tional and esthetic outcome [16]. Nevertheless, they
concluded that this product could reduce the need of
donor sites in deep dermal injuries and that the
spared donor sites can be used to cover full-thickness
wounds. In another recently published study, ReCell
was also compared with autologous meshed split
thickness skin graft for acute burn injuries and found
to be beneficial for the patients because of a de-
creased donor site size with comparable outcome.
The cell spray method can also be used for the cor-
rection of pigment disorders, as melanocytes are also
included in the cell suspension that is sprayed onto
the wound [17, 18].
Moreover, the combination of abrasion and the cell
spray procedure may allow a more aggressive treatment
of a disturbed texture, which is frequently observed after
burn injuries.
Dermal substitutes
The publications by Yannas and Burke on the basic
physical requirements of dermal substitutes heralded the
start of a new area in wound healing [19]. Following
their principles, they developed a dermal substitute with
a silicon layer on top that serves as a temporary epider-
mal cover. It became commercially available as Integra
Dermal Regeneration Template (LifeSciences Corp.,
Plainsboro, NJ, USA), and it is currently being used for
acute burns and scar reconstruction.
Various dermal substitutes have been developed like
collagen scaffolds, synthetic materials, or cadaveric skin.
These substitutes are being combined with cells, mostly
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fibroblasts, to create a living dermal substitute. Experi-
mental studies showed that dermal regeneration can be
improved and wound contraction can be reduced with
fibroblasts [20–22]. Both allogeneic and autologous
fibroblasts have been used, and it was demonstrated that
they are beneficial with respect to macroscopic as well
as histopathological results in different in vitro and
animal studies [21–25].
In a clinical study, it was shown that TransCyte®
(Smith&Nephew plc, London UK), a bioabsorbable poly-
glactin mesh seeded with allogeneic neonatal fibroblasts,
promotes re-epithelialization when used in partial-
thickness burns in children [26]. This product, however,
has only been approved as temporary skin replacement.
Obviously, allogeneic cells will finally be rejected due to
immune reactivity of the recipient [27, 28]. Allogeneic fi-
broblasts are not being used in products developed for
permanent skin replacement. The major drawback of au-
tologous fibroblasts is the delay in grafting that is caused
by the time required to culture sufficient cells.
This probably explains why acellular dermal substi-
tutes are still the most popular for clinical application.
Besides Integra, MatriDerm is now being used world-
wide on a large scale. Both are “off the shelf” substitutes
that make them more practical with fewer costs for
manufacturing. Interestingly, both are based on an engi-
neered collagen scaffold.
Integra Integra is a dermal substitute consisting of
bovine collagen and chondroitin 6-sulfate covered by a
disposable “epidermal” silicone layer. The silicone sheet
acts as a barrier against bacteria and water evaporation;
moreover, it provides mechanical support. During the first
operation of this two-staged procedure, the bilayered
membrane is applied. After 2 to 3 weeks, the silicone layer
will be removed and replaced by a thin split skin graft that
serves as an epithelial graft. In the first clinical study, a
good neodermis was provided resembling the normal
dermis [29].
Integra might be considered for extensive acute burns
mainly because it allows early removal of the eschar, and
it provides direct wound coverage. Therefore, it reduces
the need for donor sites in the beginning, which can be
crucial for the optimal final treatment. Heimbach et al.
published a multicentre trial on Integra on a large co-
hort of patients [29]. After 1 year, less hypertrophic
scarring was noted with similar appearance and function
compared to the control site. In addition, histopatho-
logical studies confirmed that patients treated with
Integra demonstrated good wound repair with a minimum
of scarring [30, 31]. The long-term results range from
normal to notable supple scar tissue. It leaves a smooth
scar where the interstices of the meshed split thickness
skin graft are hardly visible.
If Integra is used for the trunk and extremities in an ex-
tensively burned patient, it can reduce the need for donor
sites significantly at the start of treatment. A severely
burned face is also an important indication because of the
final appearance. Integra should then preferably be applied
as one unit if possible. If more than one unit has to be
used, it has been advised to apply Integra not according to
the esthetic units (because the skin grafts also have to be
situated in this way).
Moreover, severe hand burns are also being treated
with success [32–35]. In a study involving 216 burn in-
jury patients who were treated at 13 burn care facilities
in the USA, the safety and effectiveness of Integra was
evaluated [36]. Heimbach et al. showed that the mean
take rate of Integra was 76.2 % with a median take rate
of 95 %. This shows that loss of Integra should be antici-
pated. The mean take rate of epidermal autografts was
87.7 % with a median take rate of 98 %. The incidence of
invasive infection at Integra-treated sites was 3.1 % and
that of superficial infection 13.2 %. Muangman et al.
demonstrated that Integra might perform well despite
high-bacterial counts if wounds are treated with appro-
priate topical and systemic antibiotics [37]. Lohana et al.
reported overall satisfactory results to both patient and
surgeon regarding pliability, final function, and cosmetic
appearance despite the commonly observed infection at
the graft site [38].
The superior results in scarring make Integra also
feasible for scar reconstructions. Problematic scars can
be completely removed and resurfaced by Integra [39].
After 2 to 3 weeks, the silicon layer is removed and re-
placed by a very thin split thickness autograft (preferably
as full sheet). The results are good with respect to scar-
ring as it normally results in supple, normotrophic scars
[40]. Without the interposition of Integra scar formation
would probably have been worse if a thin split skin graft
was used. Does this prove that Integra is better for this
indication? There is definitely a need for well-designed
comparative, randomized, and blinded studies. But this
is practically infeasible and sometimes even unethical.
So far many have demonstrated superior results on the
use of Integra for scar reconstructions in clinical studies
[41–43]. Integra has also been applied for breast and
hand reconstruction with favorable cosmetic and func-
tional outcomes [34, 44]. Moreover, it also appears to
have a role in the reconstruction of complex defects with
exposed bones and tendons. Many reports are published
on the successful use of Integra for this type of difficult
wounds [35, 37, 45, 46]. Integra can also be used in con-
tracture release procedures [47, 48]. It has been used in
the neck, axilla, elbow, knee, hand, and other anatomical
sites. Frame et al. reported on a large cohort of con-
tracture releases in multicenter investigation. Approxi-
mately 75 % of the release sites showed a significant
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improvement in range of motion or function. But in
25 %, recurrence of contracture was observed during
follow-up monitoring [48]. Others also reported that
Integra sometimes shows re-contraction of the scar
when applied in the neck area [49]. Furthermore, the
results in children sometimes seem disappointing
because Integra could not reduce the need for reconstruct-
ive surgery [50–52]. In both situations, the “Integra-scar”
apparently could not anticipate the continuous mechanical
forces sufficiently.
To conclude, there is certainly a beneficial role of Integra
in acute burn surgery and scar reconstruction. In
acute burns, it could lead to a reduced initial need for
donor sites while it improves the quality of scarring. Then
Integra may be life-saving. For scar reconstruction, many
have demonstrated a superior outcome of scarring in
relation to the use of Integra. However, re-contraction of
Integra may occur when used for scar contracture releasing
procedures.
Matriderm MatriDerm (MedSkin Solutions Dr. Suwelack
AG, Germany) is a single layer dermal substitute that con-
sists of bovine collagen and an elastin hydrolysate. The first
clinical study was published in the year 2000 and reported
on the use of this material for acute burn wounds and scar
reconstruction procedures. It was a comparative study de-
sign where the dermal substitute was applied together with
a split skin graft and compared to the outcome of a split
skin graft alone [53]. Autograft survival was not altered by
the substitute for reconstructive wounds, but a 9 % reduc-
tion of the take rate of the autograft was established in the
burn category for substituted wounds compared with non-
substituted wounds. However, the necessity for re-grafting
was not increased by substitution [53]. Therefore, it was
concluded that this product could safely be applied in a
one-step procedure. Objective and subjective scar assess-
ment tools such as elasticity measurements, colorimetry,
and the Vancouver Scar Scale were used for the analysis. A
significant increase in elasticity of scar tissue was noted
3 months after scar reconstructions. For acute burn
wounds, this increase in elasticity was not established. It
was noted clinically that the surface roughness and texture
of the areas with dermal substitution seemed superior. Un-
fortunately, it was not possible to analyze this parameter
objectively at that time.
After 12 years, the same cohort was evaluated again
[54]. A long-lasting beneficial effect on scar quality was
demonstrated [54]. At that time, it was also possible to
perform an objective analysis of surface roughness. Sub-
jective assessment in acute and reconstructive burn scars
by means of the POSAS, the Patient and Observer Scar
Assessment Scale, showed several statistically significant
differences in favor of substituted scars [55–57]. The
analysis included pliability, relief, and the general observer
score of the POSAS. Elasticity measurements showed
higher scores for substituted scars, although the difference
was not statistically significant. Probably, the most inter-
esting finding was observed in the category of acute burn
wounds. At first sight, no benefit of the dermal substitute
could be noted in this group. However, when an analysis
was performed of those wounds which were treated with
largely expanded meshed skin grafts, a significantly higher
elasticity was found for the substituted area compared to
the control area. This finding is also clinically significant
because the application of dermal substitutes is particu-
larly warranted in severely burned patients when donor
sites are sparse and widely expanded grafts are inevitable.
Later, Bloemen et al. performed a four-armed multicen-
ter randomized controlled trial, where a split skin graft
with or without a dermal substitute and with or without
topical negative pressure was compared in patients with
deep dermal or full-thickness burns requiring skin trans-
plantation [58]. A graft take of more than 90 % was found
in all categories. An improved effectiveness of the dermal
substitute was found when combined with topical negative
pressure. In another study (concerning Integra), Moiemen
could not demonstrate increased neovascularisation by
negative pressure therapy [59].
Hur et al. studied the progress of skin graft maturation
through measuring the size of the scar in comparison
with the original wound area [60]. They showed that
grafted skin underwent contracture and remodeling for
3–6 months. Grafts on acute burns showed more con-
traction than reconstructive defects. However, the use of
MatriDerm reduced the contracture rate and enhanced
skin elasticity although the contracture rate could not be
eliminated completely by using this dermal substitute
[60, 61]. Many other studies have been performed for
acute burn wounds and scar reconstructions. Most studies
find a favorable effect of MatriDerm [62–64]. MatriDerm
has been frequently applied and tested specifically for
hand burns and reconstructions in that area with positive
results [65–68]. Demircan et al. concluded that the es-
thetic and functional results of MatriDerm in children
were encouraging [69].
MatriDerm can be applied successfully in a one-step
procedure. This can be an advantage of MatriDerm over
Integra in many burn cases, especially in scar reconstruc-
tion. However, well-designed clinical studies comparing
MatriDerm and Integra for this purpose are lacking. In a
rat model, however, no major differences in engraftment
rates or vascularisation were found when comparing
MatriDerm with Integra [70]. In a porcine full-thickness
wound model, five dermal substitutes were compared. No
long-term difference of scar quality between the different
substitutes and the control group was seen. The authors
therefore question the benefit of a two-step procedure
[71]. Nevertheless, we clearly see a role for a two-step
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procedure making use of the bilayered version of Integra in
treating extensively burned patients. Integra is also available
as a single layer now. It has been tested in a rat model
showing that both templates contain a comparable bio-
logical behavior early after transplantation. The only differ-
ences found were the faster degradation of MatriDerm and
a difference in neodermal thickness [72].
Allograft Allograft can be used as a temporary as well
as permanent skin replacement. Freeze-dried or glycero-
lized allograft is frequently used as a biological wound
dressing especially in many burn centers where early ex-
cision of the burn eschar is done routinely. Dressing
changes with allografts are performed until definitive
wound coverage is undertaken.
Allograft can also be used as a permanent replacement
for the dermis because it contains natural collagen, elas-
tin, and basement membrane structures. Cuono et al. re-
ported clinical cases on successful skin resurfacing with
an allogeneic cryopreserved dermis engrafted with cul-
tured epidermal autografts [73, 74]. The non-cellular
components of the cadaveric dermis have been shown to
be relatively non-immunogenic, but the epidermis can-
not be used as permanent coverage because of its antige-
nicity. AlloDerm® Regenerative Tissue Matrix (LifeCell
Corporation, Bridgewater, NJ, USA) is a commercially
available product that was tested for scar reconstruction
purposes. Burn scar contractures and depigmented areas
of the upper extremity were improved by a combination
of dermabrasion and an AlloDerm graft over the scar-
releasing defect [75]. There are not many studies per-
formed on AlloDerm or other allografts in the last decade
[76]. Recently, a study has been published on a glycerol
preserved acellular dermal replacement product named
Glyaderm (Euro Skin Bank, Beverwijk, The Netherlands),
which was demonstrated to serve as a dermal substitute in
acute burn wound surgery [77]. The combination of
Glyaderm® and a split thickness autograft was superior
to only a split thickness autograft at 1 year after surgery,
regarding elasticity measurements and the judgement of
blinded observers.
Although promising studies have been published, there
remains a scarcity on the studies concerning the use of
allogeneic cadaveric skin.
Cell-based skin constructs
Much progress has been made over the past decades in
the development of cell-based skin substitutes for full-
thickness skin defects. The first promising clinical re-
sults with the CEAs in the 1970s contributed to further
development of bilayered dermo-epidermal skin substi-
tutes for burn treatment. Nevertheless, there are only a
few products commercially available yet. Most of these
products consist merely of human allogeneic skin cells.
Apligraf ® (Organogenesis Inc., MA, USA) consists of
human allogeneic keratinocytes and fibroblasts derived
from neonatal foreskins seeded onto a bovine type I
collagen sponge [78–81]. The FDA approved the use of
this product for venous leg ulcer and diabetic foot ulcer.
Another example is OrCel® (Forticell Bioscience Inc., NY,
USA) in which human allogeneic epidermal keratinocytes
and dermal fibroblasts are cultured into a type I bovine
collagen sponge [82]. In the review of Debels et al., an over-
view is given of the research on the bilayered dermo-
epidermal autologous cultured skin substitute PermaDerm™
(Regenicis Inc., NY, USA), which is composed of auto-
logous cultured keratinocytes and fibroblasts onto an
absorbable collagen substrate (biomedical polymer) [83].
However, the same clinical implementation issues as
for the CEAs apply to the cell-based bilayered skin sub-
stitutes. Well-known examples are the long culture time,
limited tolerance of mechanical friction, high costs (e.g.,
production, storage, laboratory facilities, transport), and
regulatory requirement issues.
A tremendous effort has to be made by researchers
and clinicians to fulfill all the regulatory issues that
accompany the clinical application of an autologous cell-
based substitute. As a result, the evidence level of these
promising cell-based products is still limited.
In order to create and replace the complete structure of
the skin with the cosmetic appearance and all the charac-
teristics of this complicated organ, also other important
structures such as blood vessels, nerves, hair follicles, sweat
glands, and subcutaneous adipose tissue are required. Most
studies in this field are still experimental preclinical stud-
ies. To achieve vascularization in a skin substitute, different
methods are currently available and a description of these
approaches is outlined in a review of Auger et al. [84]. The
regeneration of nerves is complicated, and to our know-
ledge little is published about the implementation of nerve
regenerative cells in dermal substitutes. Hair follicle devel-
opment in dermal skin substitutes has been studied about
the differentiation of stem cells [85]. The ability of preadi-
pocytes to proliferate and differentiate after transplantation
into adipose tissue is essential to develop soft tissue in the
engineered skin. To create the subcutaneous layer of
the skin, research is performed to culture human pre-
adipocytes in scaffolds [86, 87]. Keck et al. reported
on simultaneous culturing of human preadipocytes
and keratinocytes onto a collagen-elastin scaffold [86].
Trottier et al. described in vitro production of skin
substitutes reconstructed from keratinocytes and
adipose-derived stem/stromal cells without a syn-
thetic scaffold [88].
Over the last few years, tissue engineering seems to
reach a new era by the discovery of the availability of
stem cells (SCs) [89, 90]. This new technology is of great
interest and is bringing cellular therapy at the front line
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of the field of tissue engineering for human treatment
[91]. SCs contain multilineage differentiation capacity
and immune-modulating effects [92], which make them
ideal for tissue-engineering purposes. A few clinical case
studies have shown that SCs could ameliorate burn
wound healing and even deregeneration of skin append-
ages is reported [93–95]. Until now, bone marrow-derived
mesenchymal SCs are the most favored cell type presently
under clinical trial, but the use of adipose-derived SCs is
increasing. This exciting field is associated with an in-
creasingly amount of in vitro experiments, animal models,
and clinical trials [96, 97]. However, the safety for human
use is not fully elucidated yet, and the culturing expenses
are very high. This makes the use of SCs very promising
but not common practice nowadays.
All this research on different cell types and structures
is encouraging for the exploration of combinations of all
these engineered tissues in one skin substitute. Over the
years, it may be possible to extend tissue-engineering
technologies and bioprint a 3D skin [98, 99]. All these
experimental developments may be available for clinical
studies and eventually provide an option for treatment
modalities in patients with full-thickness skin defects.
Fat
Until recently, burn specialists almost exclusively focused
on engineering of skin. However, there is an increasing
understanding of the significance of the subcutaneous
layer for the mobility and quality of the skin. This explains
the unequivocal increase in clinical studies on reconstruc-
tion of the subcutaneous layer and experimental studies
on engineering of fat.
The important role of fat for the function of the skin
becomes especially apparent in burn patients. In cases
where fascial excision was necessary, scars become dir-
ectly attached to underlying tissues such as fascia, bone,
tendon, and muscle. The mobility of those scars is con-
siderably hampered because the gliding layer is lacking.
Fortunately, adipose tissue can be easily harvested by
liposuction and used to reverse the state of damaged
tissue [100, 101]. Besides adipocytes, the harvested fat
tissue contains adipose-derived stem cells (ASCs), vascu-
lar endothelial cells (VECs), fibroblasts, pericytes, and
connective tissue as well as adipose tissue-resident mac-
rophages and lymphocytes [20, 102]. The regenerative
effect of autologous fat is considered to be derived from
ASCs. These cells comprise the potential to release
angiogenic growth factors in response to ischemic fi-
brous tissue and to differentiate into adipocytes and
VECs [103]. Moreover, 1–2 % of ASCs have the potential
to differentiate into multilineage cells (i.e., adipogenic,
chondrogenic, myogenic, and osteogenic), implicating
even more possibilities for adipose stem cell-based tissue
engineering [104]. It is hypothesized that ASCs are the
main cell population contributing to a balance between
adipocyte apoptosis/necrosis and adipogenesis after au-
tologous fat grafting [105]. This mechanism is of import-
ance when reconstructing and restoring the subcutis,
which is often destroyed in severe burns cases. As men-
tioned earlier, a burn scar will adhere to the underlying
fascia since the important quality of the subcutis as a func-
tional sliding layer is hampered. But besides restoring the
function of the subcutis, autologous fat seems to improve
the dermal quality of a scar as well. In an experimental ani-
mal study, it has been shown that fat grafting stimulates a
neosynthesis of collagen fibers at the recipient site
[106]. Another study emphasizes the suppression of
fibrogenesis after injury by ASCs secreting growth fac-
tors [107]. Clinical studies on the effect of fat grafting
in burn scars also mention favorable results in terms of
pliability. Unfortunately, the conclusions were not suffi-
ciently warranted by study design and/or the quality of
the outcome parameters [108–110]. Autologous fat
grafting is becoming a valuable addition to the recon-
structive armamentarium in burn scars; however, long-
term studies providing objective data are needed to
demonstrate its effectiveness.
Cartilage
Despite all improvements in acute burn wound treatment,
a severe facial burn injury frequently will be immensely
disfiguring. The esthetic and functional impact of a muti-
lated ear or nose is considerable. Both the ear and nose,
which are only covered by a thin skin layer, are particularly
vulnerable to thermal injury. Their structure and anatomy
is highly related to its cartilage framework directly under-
neath the skin, and this cartilage does not have regenera-
tive capacities.
In the acute phase, all exposed cartilage should be pro-
tected maximally to maintain the structure of the ear as
good as possible. If necessary, a reconstruction of the
ear is performed in a later phase. Reconstruction of ears
and noses in burn victims are still demanding surgical
procedures. It is particularly difficult due to loss of normal
skin and scarring of the surrounding tissue, which does
not facilitate coverage of the cartilage framework. The
quality of the surrounding tissue dictates the possibilities.
Costal cartilage and synthetic permanent implants
have shown their beneficial effect in ear reconstruction,
but both have their disadvantages. Creating an ear form
from costal cartilage is a quite demanding procedure,
and it does not have the same elastic properties as ear
cartilage. Synthetic permanent implants like Medpor®
have a higher risk of infection and rejection depending
on the quality of skin that covers the implant.
Tissue engineering of cartilage for nose and ear recon-
struction after a severe facial burn injury is therefore an
interesting new alternative. Individualized and customized
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constructs may be facilitated by the use of advanced 3D
bioprinting for cartilage engineering [111]. Promising re-
sults have been obtained with experimental studies; how-
ever, the transition to clinical practice is still challenging.
Tissue-engineered cartilage constructs for facial recon-
struction will hopefully find their way to the clinic within
several years.
Conclusions
Patients nowadays may survive severe burn injuries
because of the remarkable improvement in emergency
management, shock treatment, and wound care. So many
lives are being saved and extended. This calls for a para-
digm shift in treating burn patients, from short term to
long term, from survival to quality of life, and from tissue
repair to tissue regeneration.
Some types of tissue are capable of regeneration. A
good example is the epidermis; this is a highly cellular
structure with many stem cells that continuously regen-
erates itself. Other types of tissue such as the dermal
layer, the subcutaneous layer, and cartilage do not share
that possibility of regeneration after wounding. A wound
can become closed when epidermal remnants are present
in the wound. This means that the epidermal layer is
intact again; it is more or less regenerated. But it does not
mean that the dermis healed well. Also, the underlying
subcutaneous fat and cartilage show tremendous difficul-
ties in repairing itself.
This is why tissue engineering is so interesting and
why it has great potential in burn treatment in order to
improve the quality of life by improving the outcome of
burn surgery.
Since the pioneering work on epidermal and dermal
replacements, four decades have passed. A critical ap-
praisal of the literature shows that products of epidermal
regeneration are scarcely used in clinical practice.
Interestingly, the acellular dermal regeneration tem-
plates like Integra, MatriDerm, and AlloDerm are quite
frequently used. The number of well-designed clinical
studies is low, but many reports have been published
mentioning considerable success of these dermal tem-
plates. Mostly, an improvement in quality of scar tissue
was shown. This positive finding paradoxically also leads
to a negative conclusion; we are still creating scar tissue,
and therefore, we are not regenerating tissue.
All these commercially available products are typically
acellular. The implementation of cells into the engi-
neered construct may be crucial to come to true tissue
regeneration. Experimental studies on cellular constructs
are sometimes very promising, but more convincing
evidence from clinical studies would be appreciated. The
high costs and the regulatory issues do not facilitate the
transition from lab to clinical practice.
Available products like the dermal regeneration tem-
plates can be used in acute burn wounds as well as for scar
reconstructions. Dermal templates can be easily used cer-
tainly if other options like local flaps or full-thickness skin
grafts are not available for that specific scar reconstruction
procedure. Engineering of fat and cartilage is relatively
new but already promising for scar reconstruction. The
introduction of advanced 3D bioprinters may have a sig-
nificant role in tissue engineering, specifically for cartilage.
Hopefully, the patients will benefit more from future
developments in the field of tissue engineering and
regenerative medicine.
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